ORIC Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in 1L and 2L NSCLC Patients with EGFR Exon 20 Mutations at the ESMO Asia Congress 2025
December 05, 2025 20:00 ET | Source: ORIC Pharmaceuticals Highly differentiated 1L…
GTPL Hathway Ltd : Achieves robust quarterly revenue growth of 12% Y-o-Y in Q2 FY26
AHMEDABAD, India, Oct. 15, 2025 /PRNewswire/ -- GTPL Hathway Limited, India's largest…
ICMM launches a Global Mining Dataset to support more robust data on mining and metals
ICMM's new Dataset is the most comprehensive publicly available compilation of mining…
SERES Posts Robust H1 2025 Results: Revenue Hits CNY 62.4 Billion, Net Profit Up 81% to CNY 2.94 Billion, R&D Investment Soars nearly 155%
CHONGQING, China, Sept. 3, 2025 /PRNewswire/ -- On August 29, SERES announced its…
Euroclear reports robust H1 2025 results
BRUSSELS, July 18, 2025 /PRNewswire/ -- Results for the first half year…
HTX’s 2025 Mid-Year Report Showcases Robust Growth, Evidenced by 50 Million Users, $6.4 Billion Assets, and Hot Crypto’s 850% Surge
PANAMA CITY, July 17, 2025 /PRNewswire/ -- Halfway through 2025, HTX, a…
Baazar Style Retail Limited Reports Robust 37% Revenue Growth in Q1 FY26
Continues Expansion with 22 New Stores; Maintains Strong Momentum in Value Fashion…
